Warmuth Markus
President & CEO · 11 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 9,500 | $23.18 | $220,218.55 | filing |
| 2026-06-01 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 4,998 | $19.41 | $97,021.18 | filing |
| 2026-06-01 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 468 | $19.73 | $9,231.86 | filing |
| 2026-05-01 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 5,467 | $18.92 | $103,446.57 | filing |
| 2026-04-14 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 8,000 | $17.64 | $141,124.80 | filing |
| 2026-03-02 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 5,466 | $17.92 | $97,974.22 | filing |
| 2026-01-07 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 3,707 | $23.24 | $86,158.84 | filing |
| 2026-01-07 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 1,450 | $23.88 | $34,620.49 | filing |
| 2026-01-07 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 309 | $24.57 | $7,593.24 | filing |
| 2026-01-05 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 10,135 | $15.17 | $153,747.95 | filing |
| 2026-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Award | 90,000 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.